Your browser doesn't support javascript.
loading
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE-1 (phase 2) Japanese cohort.
Ri, Masaki; Suzuki, Kenshi; Ishida, Tadao; Kuroda, Junya; Tsukamoto, Taku; Teshima, Takanori; Goto, Hideki; Jackson, Carolyn C; Sun, Huabin; Pacaud, Lida; Fujikawa, Ei; Yeh, Tzu-Min; Hatayama, Tomoyoshi; Aida, Kensuke; Sunagawa, Yoshihiro; Iida, Shinsuke.
Afiliación
  • Ri M; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan.
  • Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Ishida T; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Kuroda J; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Tsukamoto T; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Teshima T; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.
  • Goto H; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.
  • Jackson CC; Janssen Research & Development, LLC; Bridgewater, New Jersey, USA.
  • Sun H; Janssen Research & Development, LLC; Bridgewater, New Jersey, USA.
  • Pacaud L; Legend Biotech, Piscataway, New Jersey, USA.
  • Fujikawa E; Janssen Pharmaceutical KK, Tokyo, Japan.
  • Yeh TM; Janssen Research & Development, LLC; Bridgewater, New Jersey, USA.
  • Hatayama T; Janssen Pharmaceutical KK, Tokyo, Japan.
  • Aida K; Janssen Pharmaceutical KK, Tokyo, Japan.
  • Sunagawa Y; Janssen Pharmaceutical KK, Tokyo, Japan.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan.
Cancer Sci ; 113(12): 4267-4276, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36052883

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón